Espoo, March 27th, 2025. Euformatics has signed a commercial contract with India-based genomics company Bencos Healthcare Solution Pvt Ltd to jointly develop clinical NGS bioinformatics solutions. This partnership aims at powering the large and fast-growing clinical genomics market in India.
The scope of the collaboration covers the infusion of Euformatics tertiary analysis of NGS data with Bencos Healthcare secondary analysis and downstream bioinformatics. Euformatics provides the OmnomicsNGS software and support for Bencos team that analyses clinical samples received from their Indian healthcare sector customers through their bioinformatics expertise. The benefits of the collaboration are demonstrated live at the 6th International GATC conference organized in Pune, India from 4th to 6th of April, 2025 through a clinical NGS workshop covering best practices, use of AI and other topics relevant to clinical interpretation of genetic variants.
Bencos is the first company to have developed clinical panels and WES capture kits in the region. Bencos further supports its clients with targeted preanalytical support to cover the entire genomics life cycle of the clinical samples. Bencos will use Genomics Hub for analyzing both rare diseases and cancer from its gene panels and whole exome sequencing (WES) data. Advanced AI functionality will be leveraged throughout the workflow from optimizing the data base to filter and prioritize clinically relevant variants with high confidence.
Subhanjan Bhowmik, the Founder & CEO of Bencos comments: ”We see a large opportunity in India for clinical NGS. Our team evaluated several alternatives for collaborating with clinically proven and best in practice NGS data tertiary analysis software and concluded that Euformatics provides the most comprehensive and competitive software that integrates best with our BI strengths. We see a huge opportunity for collaboration in building robust solutions for the Indian market together. It’s great to get their scientific leaders to jointly participate in GATC 2025 to show the joint strength of our companies in highlighting the usability, accuracy and value of the software to our customers.”
Tommi Kaasalainen, CEO of Euformatics continues: ”India is an extremely competitive market with lots of talent in IT and bioinformatics. Finding a collaborator in NGS based BI, having 14+ years of global market experience; we find Bencos is a great way for us to explore the Indian market needs, through a highly competent team of BI analysts to interpret patient data output. The GATC conference gives us a nice kick-start to the collaboration as our scientific teams get to collaborate face-to-face in Pune.”
Partnership with Bencos Research Solution is the first one for Euformatics in the Indian subcontinent. The company is committed to continuing geographical expansion through strategic and channel partnerships on all continents.
About Euformatics:
Euformatics is a Finnish software company that specialises in high-standard bioinformatics tools for genomic data interpretation. Since 2010, Euformatics has been helping medical doctors and molecular genetics laboratories provide better precision medicine for cancer and common or rare disease diagnostics. At present, our core solution is the Genomics Hub which includes a variant interpretation tool; for clinical analysis and reporting of patient NGS data and a quality control tool; for NGS data quality management.
To learn more, visit www.euformatics.com
About Bencos Research Solutions:
BENCOS RESEARCH SOLUTIONS PVT LTD is a leading genomics company based in Mumbai, Maharashtra, India, specializing in high-throughput genomics catering to the global market for the past 14+ years. It provides ultra-customized research services to research institutes, clinical institutions, hospitals, and biopharmaceutical companies, supporting them in project ideation and experimental planning to address critical biological questions and drive actionable research outcomes.
To learn more, visit www.bencoslife.com/
Press Relations:
Tommi Kaasalainen
Euformatics
tommi.kaasalainen@euformatics.com
